CN Stock MarketDetailed Quotes
000590 Tus-Pharmaceutical Group
- 8.73
- +0.47+5.69%
Not Open Nov 19 15:00 CST
2.09BMarket Cap-218250P/E (TTM)
8.78High8.26Low126.67KlotVolume8.26Open8.26Pre Close108.93MTurnover5.29%Turnover Ratio83.14P/E (Static)239.47MShares11.2552wk High3.01P/B2.09BFloat Cap4.8052wk Low9.09Limit Up239.38MShs Float35.83Historical High7.43Limit Down6.30%Amplitude1.68Historical Low--Dividend TTM8.60Avg Price53.95KlotAsk--Div YieldTTM100Lot Size69.58KlotBid
Tus-Pharmaceutical Group Key Stats
EPS
According to the latest financial report of Tus-Pharmaceutical Group, the latest earnings per share (TTM) for the company is -0.12. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Tus-Pharmaceutical Group's latest financial report to see how much their book value per share (BVPS) is currently at 2.90.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Tus-Pharmaceutical Group shows that the company's current ratio is 2.22, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Tus-Pharmaceutical Group, the quick ratio is 1.55, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Tus-Pharmaceutical Group? The latest ROE figure is -4.01%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Tus-Pharmaceutical Group, the total asset return on investment (ROA) is -2.50%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Tus-Pharmaceutical Group's latest financial report to see how their gross margin is doing - currently at 46.21%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Tus-Pharmaceutical Group, the net profit margin is -13.06%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data